Concepedia

Ulrik Mouritzen

UM

16

Publications

1.1K

Citations

15

H-Index

2002

Active since

Affiliations

Zealand Pharma (Denmark)(Current)

Center for Clinical & Basic Research

Novo Nordisk (Denmark)

Nordic Bioscience (Denmark)

Lund University

Ulrik Mouritzen is an author at Zealand Pharma (Denmark) specializing in medicine, orthopaedics, and pharmacology.

ORCID

Top concepts

Publications per year

2002–2021

16

Publications

16

Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index

Ulrik Mouritzen · Annals of the Rheumatic Diseases · 2003 · 170 citations · Full text

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial

Ian D. Davis, Ben Brady, Richard Kefford et al. · Clinical Cancer Research · 2009 · 138 citations

Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM)

Stephan Christgau, László B. Tankó, Paul A. Cloos et al. · Menopause The Journal of The North American Menopause Society · 2004 · 131 citations

, , +20

Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women

Laacuteszloacute B. Tankoacute, Lusine Movsesyan, Ulrik Mouritzen et al. · Metabolism · 2002 · 121 citations

, , +6

Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog

Ulrike Hövelmann, Britta Væver Bysted, Ulrik Mouritzen et al. · Diabetes Care · 2017 · 108 citations

Rows per page

1–5 of 16